HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara Vosoghi Selected Research

1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)

3/2018Feasibility study for production and quality control of Yb-175 as a byproduct of no carrier added Lu-177 preparation for radiolabeling of DOTMP.
1/2018Highly Stable 177Lu-Organic Framework as a Potential Agent for Treatment of Metastatic Bone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sara Vosoghi Research Topics

Disease

2Pain (Aches)
03/2018 - 01/2017
1Neoplasm Metastasis (Metastasis)
01/2018

Drug/Important Bio-Agent (IBA)

21,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA
03/2018 - 01/2018
1Metal-Organic FrameworksIBA
01/2018
1Lutetium-177IBA
01/2018
1Risedronic Acid (Actonel)FDA LinkGeneric
01/2017

Therapy/Procedure

1Therapeutics
01/2017